Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Tuberculosis (TB) is an ancient disease that has plagued humans throughout recorded and archaeology history [1]. The infection remains the cause of a higher morbidity and mortality than any other infection in the world [2]. This is because of its great prevalence in the densely populated developing countries. According to World health organization, 9 million people fell ill with TB and 1.5 million died from the disease [3]. TB is a treatable and curable disease. Active drug-sensitive TB disease is treated with a standard six-month course of four antimicrobial drugs that are provided with information, supervision and support to the patient by a health worker or trained volunteer. Without such supervision and support, treatment adherence can be difficult and the disease can spread. The vast majority of TB cases can be cured when medicines are provided and taken properly. TB was almost eradicated from the surface of earth but reemerged as a result of certain factors; mis-management of Tb treatment, poverty, increase in population, man to man transmission, crowded settings such as prisons and hospitals, malnutrition, emergence of MDRTB etc. In 2013, 480,000 people developed multidrug resistant Tb (MDRTB).
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi